Literature DB >> 7476940

[Multiple sclerosis: molecular and cellular mechanisms].

A N Boĭko, O O Favorova.   

Abstract

Multiple sclerosis (MS) is a chronic central nervous system disease of considerable medical and social impact. It is characterized by destruction of the myelin, the axon proteolipid sheath, or demyelination. While the etiology of MS remains unknown, one of the most well-grounded theories of its pathogenesis postulates that immunomediated inflammatory processes play the main role in myelin damage. The leading role in the autoimmune disturbance development belongs to T-cell system, however, B-cells also participate in the pathological process. Both genetical predisposition and environmental influence are involved in MS development. Correlations were found between MS and numerous environmental factors, including ecology and different infectious agents. However, no single environmental factor and no single infection was confirmed to be the primary cause of MS. The predisposition to MS seems to depend on several genes. Alleles and haplotypes of HLA genes which are the main human immune-response genes are undoubtedly associated with MS. Serological methods have shown weak association of MS with A3 and B7 loci of HLA class I. Stronger association was found for HLA class II haplotype specified to DR2(DR15), DQ6(DQ1) in serology typing nomenclature or DRB1*1501, DQA1*0102, DQB1*0602 in sequence-based genotyping terminology. Besides, MS was found to be associated with alleles of genes of T-cell receptors, cytokines, myelin components and some others, although these results are sometimes contradictory. The analysis of genetical predisposition factors and of possible mechanisms of their involvement in demyelination process on molecular and cellular levels should enlighten the MS pathogenesis and provide new ways of medical treatment and prevention of MS.

Entities:  

Mesh:

Year:  1995        PMID: 7476940

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  11 in total

Review 1.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.

Authors:  G A Nevinsky; Valentina N Buneva
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

2.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

3.  Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

4.  Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergey E Sedykh; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2018-09-28       Impact factor: 5.310

5.  Catalytic antibodies in the bone marrow and other organs of Th mice during spontaneous development of experimental autoimmune encephalomyelitis associated with cell differentiation.

Authors:  Kseniya S Aulova; Andrey E Urusov; Ludmila B Toporkova; Sergey E Sedykh; Yuliya A Shevchenko; Valery P Tereshchenko; Sergei V Sennikov; Thomas Budde; Sven G Meuth; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  Mol Biol Rep       Date:  2021-02-17       Impact factor: 2.316

6.  Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.

Authors:  Anna M Timofeeva; Pavel S Dmitrenok; Ludmila P Konenkova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

7.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

8.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs.

Authors:  Evgeny A Ermakov; Evelina M Kabirova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.